Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2311863-36-0
2. 3gki6rvi0v
3. (4-(6-aminopyridazin-3-yl)piperidin-1-yl)(5-(4-fluorophenoxy)-4-methoxypyridin-2-yl)methanone
4. Methanone, (4-(6-amino-3-pyridazinyl)-1-piperidinyl)(5-(4-fluorophenoxy)-4-methoxy-2-pyridinyl)-
5. [4-(6-amino-3-pyridazinyl)-1-piperidinyl][5-(4-fluorophenoxy)-4-methoxy-2-pyridinyl]methanone
6. Methanone, [4-(6-amino-3-pyridazinyl)-1-piperidinyl][5-(4-fluorophenoxy)-4-methoxy-2-pyridinyl]-
7. Refchem:196495
8. Bi 764198
9. Trpc6-in-3
10. Unii-3gki6rvi0v
11. Apecotrep
12. Apecotrep [inn]
13. Orb1687769
14. Schembl21045769
15. Schembl30386116
16. Bdbm466601
17. Us10800757, Compound 17
18. Da-78662
19. Ms-27435
20. Hy-148129
21. Cs-0613218
22. [4-(6-amino-pyridazin-3-yl)- Piperidin-1-yl]-[5-(4-fluoro-phenoxy)- 4-methoxy-pyridin-2-yl]-methanone
23. [4-(6-aminopyridazin-3-yl)piperidin-1-yl]-[5-(4-fluorophenoxy)-4-methoxypyridin-2-yl]methanone
| Molecular Weight | 423.4 g/mol |
|---|---|
| Molecular Formula | C22H22FN5O3 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 103 |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 583 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
58
PharmaCompass offers a list of BI 764198 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right BI 764198 manufacturer or BI 764198 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred BI 764198 manufacturer or BI 764198 supplier.
A BI 764198 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BI 764198, including repackagers and relabelers. The FDA regulates BI 764198 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BI 764198 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A BI 764198 supplier is an individual or a company that provides BI 764198 active pharmaceutical ingredient (API) or BI 764198 finished formulations upon request. The BI 764198 suppliers may include BI 764198 API manufacturers, exporters, distributors and traders.
BI 764198 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BI 764198 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right BI 764198 GMP manufacturer or BI 764198 GMP API supplier for your needs.
A BI 764198 CoA (Certificate of Analysis) is a formal document that attests to BI 764198's compliance with BI 764198 specifications and serves as a tool for batch-level quality control.
BI 764198 CoA mostly includes findings from lab analyses of a specific batch. For each BI 764198 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BI 764198 may be tested according to a variety of international standards, such as European Pharmacopoeia (BI 764198 EP), BI 764198 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BI 764198 USP).
